Form 8-K 9.17.14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 12, 2014
Cardiovascular Systems, Inc.
(Exact name of Registrant as Specified in its Charter)
|
| | | | |
| | | | |
Delaware | | 000-52082 | | 41-1698056 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
651 Campus Drive
St. Paul, Minnesota 55112-3495
(Address of Principal Executive Offices and Zip Code)
(651) 259-1600
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
| |
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
| |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
| |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
| |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 12, 2014, Dr. Glen Nelson, the current Chairman of the Board of Directors (the “Board”) of Cardiovascular Systems, Inc. (the “Company”), provided the Board with notice of his intent not to stand for reelection to the Board of Directors of the Company at the 2014 Annual Meeting of Stockholders. Dr. Nelson’s decision not to pursue reelection was not due to a disagreement with the Company. Dr. Nelson will continue to serve as a director of the Company until the expiration of his term at the 2014 Annual Meeting of Stockholders.
On September 17, 2014, the Company issued a press release regarding Dr. Nelson’s decision not to stand for reelection. A copy of the Company’s press release is attached as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
|
| | |
| | |
Exhibit Number | | Description |
| |
99.1 | | Press Release dated September 17, 2014. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 17, 2014
|
| | |
| | |
CARDIOVASCULAR SYSTEMS, INC. |
By: | | /s/ Laurence L. Betterley |
| | Laurence L. Betterley Chief Financial Officer |
EXHIBIT INDEX
|
| | |
| | |
Exhibit Number | | Description |
| |
99.1 | | Press Release dated September 17, 2014. |